Standard BioTools Inc.

NASDAQ: LAB · Real-Time Price · USD
1.22
0.00 (0.00%)
At close: Aug 15, 2025, 12:12 PM

Standard BioTools Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-138.88M -74.66M -190.1M -59.24M
Depreciation & Amortization
16.86M 15.18M 15.03M 15.57M
Stock-Based Compensation
31.73M 13.12M 14.88M 16.1M
Other Working Capital
-15.31M 8.07M -5.3M -23.16M
Other Non-Cash Items
-23.96M 1.28M 86.3M 3.42M
Deferred Income Tax
n/a n/a n/a 21K
Change in Working Capital
-29.2M 1.79M -15.48M -19.93M
Operating Cash Flow
-143.45M -43.29M -89.37M -44.06M
Capital Expenditures
-8.36M -2.83M -3.83M -13.26M
Cash Acquisitions
-1.39M n/a 84.3M n/a
Purchase of Investments
-256.12M -94.9M -137.3M n/a
Sales Maturities Of Investments
349M 117.96M 53M n/a
Other Investing Acitivies
280.03M n/a -84.3M 1.32M
Investing Cash Flow
363.17M 20.24M -88.13M -11.95M
Debt Repayment
-63.19M -2.08M 18.16M 16.34M
Common Stock Repurchased
-40.49M -5.41M -563K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.07M 827K -11.84M 1.42M
Financial Cash Flow
-102.62M -6.81M 230.76M 15.96M
Net Cash Flow
116.32M -29.82M 52.86M -40.07M
Free Cash Flow
-151.81M -46.12M -93.19M -57.33M